These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1457941)

  • 1. Binding kinetics of thrombin and antithrombin III with immobilized heparin using a spacer.
    Byun Y; Jacobs HA; Kim SW
    ASAIO J; 1992; 38(3):M649-53. PubMed ID: 1457941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin surface immobilization through hydrophilic spacers: thrombin and antithrombin III binding kinetics.
    Byun Y; Jacobs HA; Kim SW
    J Biomater Sci Polym Ed; 1994; 6(1):1-13. PubMed ID: 7947469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
    Byun Y; Jacobs HA; Kim SW
    Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fibronectin on the binding of antithrombin III to immobilized heparin.
    Byun Y; Jacobs HA; Feijen J; Kim SW
    J Biomed Mater Res; 1996 Jan; 30(1):95-100. PubMed ID: 8788110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interactions between antithrombin III, thrombin and surface immobilized heparin.
    van Delden CJ; Engbers GH; Feijen J
    J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms.
    Carlson TH; Kolman MR; Frees A; Babcock T
    Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of blood coagulation at heparin-coated surfaces.
    Blezer R; Fouache B; Willems GM; Lindhout T
    J Biomed Mater Res; 1997 Oct; 37(1):108-13. PubMed ID: 9335355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin immobilization by surface amplification.
    Piao AZ; Jacobs HA; Park KD; Kim SW
    ASAIO J; 1992; 38(3):M638-43. PubMed ID: 1457939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein binding properties to immobilized heparin and heparin-albumin conjugate.
    Mirow N; Zimmermann B; Maleszka A; Knobl H; Tenderich G; Koerfer R; Herberg FW
    Artif Organs; 2007 Jun; 31(6):466-71. PubMed ID: 17537059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
    Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
    Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparinization of gas plasma-modified polystyrene surfaces and the interactions of these surfaces with proteins studied with surface plasmon resonance.
    van Delden CJ; Lens JP; Kooyman RP; Engbers GH; Feijen J
    Biomaterials; 1997 Jun; 18(12):845-52. PubMed ID: 9184748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
    Smith BA; Sefton MV
    J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
    Nesheim M; Blackburn MN; Lawler CM; Mann KG
    J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1.
    Rovelli G; Stone SR; Guidolin A; Sommer J; Monard D
    Biochemistry; 1992 Apr; 31(13):3542-9. PubMed ID: 1554734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of antithrombin III with surface-immobilized albumin-heparin conjugates.
    van Delden CJ; Engbers GH; Feijen J
    J Biomed Mater Res; 1995 Nov; 29(11):1317-29. PubMed ID: 8582900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.